{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:36:12Z","timestamp":1778132172369,"version":"3.51.4"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Council of Scientific and Industrial Research and University Grant Commission, New Delhi, India","award":["221610113486"],"award-info":[{"award-number":["221610113486"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00204-024-03861-9","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:10:36Z","timestamp":1726243836000},"page":"3585-3601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The phytochemical plumbagin: mechanism behind its \u201cpleiotropic\u201d nature and potential as an anticancer treatment"],"prefix":"10.1007","volume":"98","author":[{"given":"Shikshya Swarupa","family":"Panda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5609-7660","authenticated-orcid":false,"given":"Bijesh Kumar","family":"Biswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"issue":"16","key":"3861_CR1","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1002\/pros.23428","volume":"77","author":"P Abedinpour","year":"2017","unstructured":"Abedinpour P, Baron VT, Chrastina A et al (2017) Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: a pre-clinical study. Prostate 77(16):1550\u20131562. https:\/\/doi.org\/10.1002\/pros.23428","journal-title":"Prostate"},{"issue":"4","key":"3861_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/exd.14079","volume":"29","author":"FZ Alem","year":"2020","unstructured":"Alem FZ, Bejaoui M, Villareal MO, Rhourri-Frih B, Isoda H (2020) Elucidation of the effect of plumbagin on the metastatic potential of B16F10 murine melanoma cells via MAPK signaling pathway. Exp Dermatol 29(4):427\u2013435. https:\/\/doi.org\/10.1111\/exd.14079","journal-title":"Exp Dermatol"},{"key":"3861_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/b978-0-12-817901-7.00013-7","volume":"63","author":"HR Badwaik","year":"2019","unstructured":"Badwaik HR, Kumari L, Nakhate K, Verma VS, Sakure K (2019) Phytoconstituent plumbagin: chemical, biotechnological and pharmaceutical aspects. Stud Nat Prod Chem 63:415\u2013460. https:\/\/doi.org\/10.1016\/b978-0-12-817901-7.00013-7","journal-title":"Stud Nat Prod Chem"},{"key":"3861_CR4","doi-asserted-by":"publisher","first-page":"109582","DOI":"10.1016\/j.cbi.2021.109582","volume":"347","author":"IJ Bello","year":"2021","unstructured":"Bello IJ, Oyebode OT, Olanlokun JO, Omodara TO, Olorunsogo OO (2021) Plumbagin induces testicular damage via mitochondrial-dependent cell death. Chem Biol Interact 347:109582. https:\/\/doi.org\/10.1016\/j.cbi.2021.109582","journal-title":"Chem Biol Interact"},{"key":"3861_CR5","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/ad1dff","author":"S Bhagat","year":"2024","unstructured":"Bhagat S, Singh S (2024) Use of antioxidant nano-liposomes for co-delivery of PTEN plasmids and plumbagin to induce apoptosis in hepatic cancer cells. Biomed Mater. https:\/\/doi.org\/10.1088\/1748-605X\/ad1dff","journal-title":"Biomed Mater"},{"issue":"2","key":"3861_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s12276-021-00560-8","volume":"53","author":"KR Bhattarai","year":"2021","unstructured":"Bhattarai KR, Riaz TA, Kim HR, Chae HJ (2021) The aftermath of the interplay between the endoplasmic reticulum stress response and redox signaling. Exp Mol Med 53(2):151\u2013167. https:\/\/doi.org\/10.1038\/s12276-021-00560-8","journal-title":"Exp Mol Med"},{"key":"3861_CR7","doi-asserted-by":"publisher","first-page":"108733","DOI":"10.1016\/j.cbi.2019.108733","volume":"310","author":"A Binoy","year":"2019","unstructured":"Binoy A, Nedungadi D, Katiyar N et al (2019) Plumbagin induces paraptosis in cancer cells by disrupting the sulfhydryl homeostasis and proteasomal function. Chem Biol Interact 310:108733. https:\/\/doi.org\/10.1016\/j.cbi.2019.108733","journal-title":"Chem Biol Interact"},{"key":"3861_CR8","doi-asserted-by":"crossref","unstructured":"Bloch K, Parihar VS, Kellom\u00e4ki M, Thongmee S, Ghosh S (2023) Therapeutic phytochemicals from Plumbago auriculata: a drug discovery paradigm Recent Frontiers of Phytochemicals. Elsevier, p 189\u2013201","DOI":"10.1016\/B978-0-443-19143-5.00027-X"},{"issue":"1","key":"3861_CR9","doi-asserted-by":"publisher","first-page":"18566","DOI":"10.1038\/s41598-023-45832-7","volume":"13","author":"R Cai","year":"2023","unstructured":"Cai R, Tressler CM, Cheng M et al (2023) Primary breast tumor induced extracellular matrix remodeling in premetastatic lungs. Sci Rep 13(1):18566","journal-title":"Sci Rep"},{"issue":"2","key":"3861_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41419-017-0068-6","volume":"9","author":"Y-Y Cao","year":"2018","unstructured":"Cao Y-Y, Yu J, Liu T-T et al (2018) Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling. Cell Death Dis 9(2):17. https:\/\/doi.org\/10.1038\/s41419-017-0068-6","journal-title":"Cell Death Dis"},{"issue":"6","key":"3861_CR11","doi-asserted-by":"publisher","first-page":"e09519","DOI":"10.1016\/j.heliyon.2022.e09519","volume":"8","author":"AM Castaneda","year":"2022","unstructured":"Castaneda AM, Melendez CM, Uribe D, Pedroza-Diaz J (2022) Synergistic effects of natural compounds and conventional chemotherapeutic agents: recent insights for the development of cancer treatment strategies. Heliyon 8(6):e09519. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09519","journal-title":"Heliyon"},{"key":"3861_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.freeradbiomed.2019.09.001","volume":"143","author":"R Checker","year":"2019","unstructured":"Checker R, Pal D, Patwardhan RS, Basu B, Sharma D, Sandur SK (2019) Modulation of Caspase-3 activity using a redox active vitamin K3 analogue, plumbagin, as a novel strategy for radioprotection. Free Radical Bio Med 143:560\u2013572. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.09.001","journal-title":"Free Radical Bio Med"},{"issue":"1","key":"3861_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12906-018-2155-3","volume":"18","author":"H Chen","year":"2018","unstructured":"Chen H, Wang H, An J, Shang Q, Ma J (2018) Plumbagin induces RPE cell cycle arrest and apoptosis via p38 MARK and PI3K\/AKT\/mTOR signaling pathways in PVR. BMC Complement Altern Med 18(1):89. https:\/\/doi.org\/10.1186\/s12906-018-2155-3","journal-title":"BMC Complement Altern Med"},{"key":"3861_CR14","doi-asserted-by":"publisher","first-page":"9035452","DOI":"10.1155\/2018\/9035452","volume":"2018","author":"A Chrastina","year":"2018","unstructured":"Chrastina A, Baron VT, Abedinpour P, Rondeau G, Welsh J, Borgstrom P (2018) Plumbagin-loaded nanoemulsion drug delivery formulation and evaluation of anti-proliferative effect on prostate cancer cells. Biomed Res Int 2018:9035452. https:\/\/doi.org\/10.1155\/2018\/9035452","journal-title":"Biomed Res Int"},{"issue":"1","key":"3861_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2174\/1872210516666220131092642","volume":"17","author":"CR de Oliveira","year":"2023","unstructured":"de Oliveira CR, Droppa-Almeida D, Padilha FF, de Souza RR, de Albuquerque-J\u00fanior RL (2023) Polymeric nano-particles for the treatment of prostate cancer-technological prospecting and critical analysis. Recent Pat Nanotechnol 17(1):8\u201314. https:\/\/doi.org\/10.2174\/1872210516666220131092642","journal-title":"Recent Pat Nanotechnol"},{"issue":"8","key":"3861_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM (2023) Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol 24(8):560\u2013575. https:\/\/doi.org\/10.1038\/s41580-023-00585-z","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"3861_CR17","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3892\/ijo.2014.2592","volume":"45","author":"B Eldhose","year":"2014","unstructured":"Eldhose B, Gunawan M, Rahman M, Latha MS, Notario V (2014) Plumbagin reduces human colon cancer cell survival by inducing cell cycle arrest and mitochondria-mediated apoptosis. Int J Oncol 45(5):1913\u20131920. https:\/\/doi.org\/10.3892\/ijo.2014.2592","journal-title":"Int J Oncol"},{"key":"3861_CR18","doi-asserted-by":"publisher","first-page":"891652","DOI":"10.3389\/fonc.2022.891652","volume":"12","author":"TB Emran","year":"2022","unstructured":"Emran TB, Shahriar A, Mahmud AR et al (2022) Multidrug resistance in cancer: understanding molecular mechanisms immunoprevention and therapeutic approaches. Front Oncol 12:891652. https:\/\/doi.org\/10.3389\/fonc.2022.891652","journal-title":"Front Oncol"},{"issue":"1","key":"3861_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y (2020) Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther 5(1):28. https:\/\/doi.org\/10.1038\/s41392-020-0134-x","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3861_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3892\/or.2021.7933","volume":"45","author":"XJ Fu","year":"2021","unstructured":"Fu XJ, Cui JJ, Meng XJ et al (2021) Endoplasmic reticulum stress, cell death and tumor: association between endoplasmic reticulum stress and the apoptosis pathway in tumors. Oncol Rep 45(3):801\u2013808. https:\/\/doi.org\/10.3892\/or.2021.7933","journal-title":"Oncol Rep"},{"issue":"1","key":"3861_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-023-01849-0","volume":"22","author":"KR Gajbhiye","year":"2023","unstructured":"Gajbhiye KR, Salve R, Narwade M, Sheikh A, Kesharwani P, Gajbhiye V (2023) Lipid polymer hybrid nano-particles: a custom-tailored next-generation approach for cancer therapeutics. Mol Cancer 22(1):160. https:\/\/doi.org\/10.1186\/s12943-023-01849-0","journal-title":"Mol Cancer"},{"issue":"10","key":"3861_CR22","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.21873\/anticanres.15287","volume":"41","author":"R Gharbaran","year":"2021","unstructured":"Gharbaran R, Shi C, Onwumere O, Redenti S (2021) Plumbagin induces cytotoxicity via loss of mitochondrial membrane potential and caspase activation in metastatic retinoblastoma. Anticancer Res 41(10):4725\u20134732. https:\/\/doi.org\/10.21873\/anticanres.15287","journal-title":"Anticancer Res"},{"key":"3861_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/1934578x20921627","author":"I Giacomini","year":"2020","unstructured":"Giacomini I, Cocetta V, Carrara M, Ragazzi E, Montopoli M (2020) Plumbagin induces cell cycle arrest and apoptosis in A431 cisplatin-resistant cancer cells. Nat Prod Commun. https:\/\/doi.org\/10.1177\/1934578x20921627","journal-title":"Nat Prod Commun"},{"issue":"3","key":"3861_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/1535-7163.MCT-16-0285","volume":"16","author":"R Gowda","year":"2017","unstructured":"Gowda R, Kardos G, Sharma A, Singh S, Robertson GP (2017) Nanoparticle-based celecoxib and plumbagin for the synergistic treatment of melanoma. Mol Cancer Ther 16(3):440\u2013452. https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0285","journal-title":"Mol Cancer Ther"},{"issue":"13","key":"3861_CR25","doi-asserted-by":"publisher","first-page":"6861","DOI":"10.3390\/ijms22136861","volume":"22","author":"H-H Guan","year":"2021","unstructured":"Guan H-H, Huang Y-H, Lin E-S, Chen C-J, Huang C-Y (2021) Plumbagin, a natural product with potent anticancer activities, binds to and inhibits dihydroorotase, a key enzyme in pyrimidine biosynthesis. Int J Mol Sci 22(13):6861","journal-title":"Int J Mol Sci"},{"key":"3861_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/cnr2.1715","volume":"5","author":"S Gupta","year":"2022","unstructured":"Gupta S, Verma V, Dwarakanath BS (2022) Emerging concepts in cancer therapy: mechanisms of resistance. Cancer Rep 5:12. https:\/\/doi.org\/10.1002\/cnr2.1715","journal-title":"Cancer Rep"},{"issue":"12","key":"3861_CR27","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1093\/carcin\/bgs291","volume":"33","author":"BB Hafeez","year":"2012","unstructured":"Hafeez BB, Zhong W, Mustafa A, Fischer JW, Witkowsky O, Verma AK (2012) Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKC\u03b5, Stat3 and neuroendocrine markers. Carcinogenesis 33(12):2586\u20132592. https:\/\/doi.org\/10.1093\/carcin\/bgs291","journal-title":"Carcinogenesis"},{"key":"3861_CR28","doi-asserted-by":"publisher","first-page":"1159409","DOI":"10.3389\/fphar.2023.1159409","volume":"14","author":"S Hanson","year":"2023","unstructured":"Hanson S, Dharan A, Jinsha PV et al (2023) Paraptosis: a unique cell death mode for targeting cancer. Front Pharmacol 14:1159409","journal-title":"Front Pharmacol"},{"issue":"1","key":"3861_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000486773","volume":"45","author":"H Huang","year":"2018","unstructured":"Huang H, Xie H, Pan Y, Zheng K, Xia Y, Chen W (2018) Plumbagin triggers ER stress-mediated apoptosis in prostate cancer cells via induction of ROS. Cell Physiol Biochem 45(1):267\u2013280. https:\/\/doi.org\/10.1159\/000486773","journal-title":"Cell Physiol Biochem"},{"issue":"56","key":"3861_CR30","doi-asserted-by":"publisher","first-page":"32022","DOI":"10.1039\/c8ra05339a","volume":"8","author":"A Jaiswal","year":"2018","unstructured":"Jaiswal A, Sabarwal A, Narayan Mishra JP, Singh RP (2018) Plumbagin induces ROS-mediated apoptosis and cell cycle arrest and inhibits EMT in human cervical carcinoma cells. RSC Adv 8(56):32022\u201332037. https:\/\/doi.org\/10.1039\/c8ra05339a","journal-title":"RSC Adv"},{"issue":"17","key":"3861_CR31","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.3390\/molecules27175716","volume":"27","author":"S Jampasri","year":"2022","unstructured":"Jampasri S, Reabroi S, Tungmunnithum D, Parichatikanond W, Pinthong D (2022) Plumbagin suppresses breast cancer progression by downregulating HIF-1\u03b1 expression via a PI3K\/Akt\/MTOR independent pathway under hypoxic condition. Molecules 27(17):5716. https:\/\/doi.org\/10.3390\/molecules27175716","journal-title":"Molecules"},{"key":"3861_CR32","doi-asserted-by":"publisher","first-page":"105656","DOI":"10.1016\/j.phrs.2021.105656","volume":"169","author":"ZB Jiang","year":"2021","unstructured":"Jiang ZB, Xu C, Wang WJ et al (2021) Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8 T cells. Pharmacol Res 169:105656","journal-title":"Pharmacol Res"},{"issue":"1","key":"3861_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1055\/a-1332-2037","volume":"88","author":"PR Kamble","year":"2022","unstructured":"Kamble PR, Shaikh KS (2022) Optimization and evaluation of self-nanoemulsifying drug delivery system for enhanced bioavailability of plumbagin. Planta Med 88(1):79\u201390. https:\/\/doi.org\/10.1055\/a-1332-2037","journal-title":"Planta Med"},{"issue":"1","key":"3861_CR34","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41598-018-19261-w","volume":"8","author":"A Kapur","year":"2018","unstructured":"Kapur A, Beres T, Rathi K et al (2018) Oxidative stress via inhibition of the mitochondrial electron transport and Nrf-2-mediated anti-oxidative response regulate the cytotoxic activity of plumbagin. Sci Rep 8(1):1073. https:\/\/doi.org\/10.1038\/s41598-018-19261-w","journal-title":"Sci Rep"},{"issue":"6","key":"3861_CR35","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.3892\/or.2017.5627","volume":"37","author":"X Kong","year":"2017","unstructured":"Kong X, Luo J, Xu T et al (2017) Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi-1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP. Oncol Rep 37(6):3423\u20133432. https:\/\/doi.org\/10.3892\/or.2017.5627","journal-title":"Oncol Rep"},{"issue":"1","key":"3861_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41419-023-05583-9","volume":"14","author":"P Konieczny","year":"2023","unstructured":"Konieczny P, Adamus T, Sulkowski M, Skrzypek K, Majka M (2023) Impact of AMPK on cervical carcinoma progression and metastasis. Cell Death Dis 14(1):43. https:\/\/doi.org\/10.1038\/s41419-023-05583-9","journal-title":"Cell Death Dis"},{"key":"3861_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.720076","author":"H Kumar","year":"2022","unstructured":"Kumar H, Kumar RM, Bhattacharjee D, Somanna P, Jain V (2022) Role of Nrf2 signaling cascade in breast cancer: strategies and treatment. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.720076","journal-title":"Front Pharmacol"},{"key":"3861_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-0602-4_4","author":"Y Li","year":"2019","unstructured":"Li Y, Chen Y (2019) AMPK and autophagy. Autophagy Biol Dis Basic Sci. https:\/\/doi.org\/10.1007\/978-981-15-0602-4_4","journal-title":"Autophagy Biol Dis Basic Sci"},{"key":"3861_CR39","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S200610","author":"T Li","year":"2019","unstructured":"Li T, Lv M, Chen X, Yu Y, Zang G, Tang Z (2019) Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA. Drug Des Develop Therapy. https:\/\/doi.org\/10.2147\/DDDT.S200610","journal-title":"Drug Des Develop Therapy"},{"key":"3861_CR40","doi-asserted-by":"publisher","first-page":"104208","DOI":"10.1016\/j.bioorg.2020.104208","volume":"104","author":"N Li","year":"2020","unstructured":"Li N, Ou JF, Bao N et al (2020) Design, synthesis and biological evaluation of novel plumbagin derivatives as potent anti-tumor agents with STAT3 inhibition. Bioorg Chem 104:104208","journal-title":"Bioorg Chem"},{"issue":"12","key":"3861_CR41","doi-asserted-by":"publisher","first-page":"5460","DOI":"10.1002\/jsfa.11900","volume":"102","author":"X Liang","year":"2022","unstructured":"Liang X, Pan Q, Liao Y et al (2022) In silico analysis and experimental validation to exhibit anti-nasopharyngeal carcinoma effects of plumbagin, an anticancer compound. Sci Food Agric 102(12):5460\u20135467. https:\/\/doi.org\/10.1002\/jsfa.11900","journal-title":"Sci Food Agric"},{"issue":"6","key":"3861_CR42","doi-asserted-by":"publisher","first-page":"9820","DOI":"10.1002\/jcb.28262","volume":"120","author":"Y Lin","year":"2019","unstructured":"Lin Y, Chen Y, Wang S et al (2019a) Plumbagin induces autophagy and apoptosis of SMMC-7721 cells in vitro and in vivo. Cell Biochem 120(6):9820\u20139830. https:\/\/doi.org\/10.1002\/jcb.28262","journal-title":"Cell Biochem"},{"issue":"6","key":"3861_CR43","doi-asserted-by":"publisher","first-page":"9820","DOI":"10.1002\/jcb.28262","volume":"120","author":"Y Lin","year":"2019","unstructured":"Lin Y, Chen Y, Wang S et al (2019b) Plumbagin induces autophagy and apoptosis of SMMC-7721 cells in vitro and in vivo. J Cell Biochem 120(6):9820\u20139830. https:\/\/doi.org\/10.1002\/jcb.28262","journal-title":"J Cell Biochem"},{"key":"3861_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154655","author":"C-L Lin","year":"2023","unstructured":"Lin C-L, Yu C-I, Lee T-H et al (2023a) Plumbagin induces the apoptosis of drug-resistant oral cancer in vitro and in vivo through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction. Phytomedicine. https:\/\/doi.org\/10.1016\/j.phymed.2023.154655","journal-title":"Phytomedicine"},{"key":"3861_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154655","author":"CL Lin","year":"2023","unstructured":"Lin CL, Yu CI, Lee TH et al (2023b) Plumbagin induces the apoptosis of drug-resistant oral cancer and through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction. Phytomedicine. https:\/\/doi.org\/10.1016\/j.phymed.2023.154655","journal-title":"Phytomedicine"},{"issue":"7","key":"3861_CR46","doi-asserted-by":"publisher","first-page":"6279","DOI":"10.3390\/ijms24076279","volume":"24","author":"H Liu","year":"2023","unstructured":"Liu H, Zhang W, Jin L, Liu S, Liang L, Wei Y (2023) Plumbagin exhibits genotoxicity and induces G2\/M cell cycle arrest via ROS-mediated oxidative stress and activation of ATM-p53 signaling pathway in hepatocellular cells. Int J Mol Sci 24(7):6279. https:\/\/doi.org\/10.3390\/ijms24076279","journal-title":"Int J Mol Sci"},{"key":"3861_CR47","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/cells12040611","volume":"12","author":"K Lyamzaev","year":"2023","unstructured":"Lyamzaev K, Panteleeva A, Simonyan R, Avetisyan A, Chernyak B (2023) Mitochondrial lipid peroxidation is responsible for ferroptosis. Cells 12:611","journal-title":"Cells"},{"issue":"39","key":"3861_CR48","doi-asserted-by":"publisher","first-page":"25299","DOI":"10.1021\/acsomega.1c03081","volume":"6","author":"IS Mahmoud","year":"2021","unstructured":"Mahmoud IS, Hatmal MM, Abuarqoub D et al (2021) 1,4-naphthoquinone is a potent inhibitor of IRAK1 kinases and the production of inflammatory cytokines in THP-1 differentiated macrophages. ACS Omega 6(39):25299\u201325310. https:\/\/doi.org\/10.1021\/acsomega.1c03081","journal-title":"ACS Omega"},{"issue":"6","key":"3861_CR49","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/nu11061294","volume":"11","author":"D Majiene","year":"2019","unstructured":"Majiene D, Kuseliauskyte J, Stimbirys A, Jekabsone A (2019) Comparison of the effect of native 1,4-naphthoquinones plumbagin, menadione, and lawsone on viability, redox status, and mitochondrial functions of C6 glioblastoma cells. Nutrients 11(6):1294. https:\/\/doi.org\/10.3390\/nu11061294","journal-title":"Nutrients"},{"key":"3861_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201116","author":"SS Messeha","year":"2018","unstructured":"Messeha SS, Zarmouh NO, Mendonca P, Alwagdani H, Kolta MG, Soliman KFA (2018) The inhibitory effects of plumbagin on the NF-\u049bB pathway and CCL2 release in racially different triple-negative breast cancer cells. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0201116","journal-title":"PLoS ONE"},{"key":"3861_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.adcanc.2022.100027","author":"S Mohapatra","year":"2022","unstructured":"Mohapatra S, Mohanty J, Pani S et al (2022) Root extract of Plumbago zeylanica L induces cytotoxicity, inhibits cell migration and induces S-phase cell cycle arrest through down regulation of EGFR in HeLa cervical cancer cells. Adv Cancer Biol Metast. https:\/\/doi.org\/10.1016\/j.adcanc.2022.100027","journal-title":"Adv Cancer Biol Metast"},{"key":"3861_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202200471","author":"NS Mone","year":"2023","unstructured":"Mone NS, Syed S, Ravichandiran P, Satpute SK, Kim AR, Yoo DJ (2023) How structure-function relationships of 1, 4-naphthoquinones combat antimicrobial resistance in multidrug-resistant (MDR) pathogens. ChemMedChem. https:\/\/doi.org\/10.1002\/cmdc.202200471","journal-title":"ChemMedChem"},{"issue":"3","key":"3861_CR53","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1021\/acsomega.2c06691","volume":"8","author":"S Mukherjee","year":"2023","unstructured":"Mukherjee S, Sawant AV, Prassanawar SS, Panda D (2023) Copper-plumbagin complex produces potent anticancer effects by depolymerizing microtubules and inducing reactive oxygen species and DNA damage. ACS Omega 8(3):3221\u20133235. https:\/\/doi.org\/10.1021\/acsomega.2c06691","journal-title":"ACS Omega"},{"issue":"23","key":"3861_CR54","doi-asserted-by":"publisher","first-page":"8367","DOI":"10.3390\/molecules27238367","volume":"27","author":"A Naeem","year":"2022","unstructured":"Naeem A, Hu P, Yang M et al (2022) Natural products as anticancer agents: current status and future perspectives. Molecules 27(23):8367. https:\/\/doi.org\/10.3390\/molecules27238367","journal-title":"Molecules"},{"key":"3861_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102804","author":"A Nair","year":"2021","unstructured":"Nair A, Nair SC, Banerji A, Biswas R, Mony U (2021) Development and evaluation of plumbagin-loaded chitin hydrogel for the treatment of skin cancer. J Drug Deliv Sci Tec. https:\/\/doi.org\/10.1016\/j.jddst.2021.102804","journal-title":"J Drug Deliv Sci Tec"},{"issue":"10","key":"3861_CR56","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1111\/cas.15068","volume":"112","author":"H Nakamura","year":"2021","unstructured":"Nakamura H, Takada K (2021) Reactive oxygen species in cancer: current findings and future directions. Cancer Sci 112(10):3945\u20133952. https:\/\/doi.org\/10.1111\/cas.15068","journal-title":"Cancer Sci"},{"issue":"6","key":"3861_CR57","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/pharmaceutics14061303","volume":"14","author":"C Navarro","year":"2022","unstructured":"Navarro C, Ortega A, Santeliz R et al (2022) Metabolic reprogramming in cancer cells: emerging molecular mechanisms and novel therapeutic approaches. Pharmaceutics 14(6):1303. https:\/\/doi.org\/10.3390\/pharmaceutics14061303","journal-title":"Pharmaceutics"},{"issue":"2","key":"3861_CR58","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1002\/mco2.218","volume":"4","author":"S Nong","year":"2023","unstructured":"Nong S, Han X, Xiang Y et al (2023) Metabolic reprogramming in cancer: mechanisms and therapeutics. MedComm 4(2):e218. https:\/\/doi.org\/10.1002\/mco2.218","journal-title":"MedComm"},{"issue":"21","key":"3861_CR59","doi-asserted-by":"publisher","first-page":"13293","DOI":"10.3390\/ijms232113293","volume":"23","author":"KR Olson","year":"2022","unstructured":"Olson KR, Clear KJ, Derry PJ et al (2022) Naphthoquinones oxidize H2S to polysulfides and thiosulfate, implications for therapeutic applications. Int J Mol Sci 23(21):13293. https:\/\/doi.org\/10.3390\/ijms232113293","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3861_CR60","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.3390\/ijms24087516","volume":"24","author":"KR Olson","year":"2023","unstructured":"Olson KR, Clear KJ, Gao Y et al (2023) Redox and nucleophilic reactions of naphthoquinones with small thiols and their effects on oxidization of HS to inorganic and organic hydropolysulfides and thiosulfate. Int J Mol Sci 24(8):7516","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3861_CR61","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3390\/ijms25042340","volume":"25","author":"R Palanisamy","year":"2024","unstructured":"Palanisamy R, Indrajith Kahingalage N, Archibald D, Casari I, Falasca M (2024) Synergistic anticancer activity of plumbagin and xanthohumol combination on pancreatic cancer models. Int J Mol Sci 25(4):2340. https:\/\/doi.org\/10.3390\/ijms25042340","journal-title":"Int J Mol Sci"},{"key":"3861_CR62","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.12659\/MSM.917240","volume":"25","author":"Q Pan","year":"2019","unstructured":"Pan Q, Zhou R, Su M, Li R (2019) The effects of plumbagin on pancreatic cancer: a mechanistic network pharmacology approach. Med Sci Monit 25:4648\u20134654. https:\/\/doi.org\/10.12659\/MSM.917240","journal-title":"Med Sci Monit"},{"key":"3861_CR63","doi-asserted-by":"publisher","first-page":"8239984","DOI":"10.1155\/2021\/8239984","volume":"2021","author":"ST Pan","year":"2021","unstructured":"Pan ST, Huang G, Wang Q, Qiu JX (2021) Plumbagin enhances the radiosensitivity of tongue squamous cell carcinoma cells via downregulating ATM. Oncol 2021:8239984. https:\/\/doi.org\/10.1155\/2021\/8239984","journal-title":"Oncol"},{"issue":"6","key":"3861_CR64","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1007\/s11033-020-05464-w","volume":"47","author":"M Panda","year":"2020","unstructured":"Panda M, Tripathi SK, Biswal BK (2020) Plumbagin promotes mitochondrial-mediated apoptosis in gefitinib-sensitive and resistant A549 lung cancer cell line through enhancing reactive oxygen species generation. Mol Biol Rep 47(6):4155\u20134168. https:\/\/doi.org\/10.1007\/s11033-020-05464-w","journal-title":"Mol Biol Rep"},{"issue":"1","key":"3861_CR65","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5114\/aoms.2020.101072","volume":"18","author":"VS Periasamy","year":"2022","unstructured":"Periasamy VS, Athinarayanan J, Ramankutty G, Akbarsha MA, Alshatwi AA (2022) Plumbagin triggers redox-mediated autophagy through the LC3B protein in human papillomavirus-positive cervical cancer cells. Arch Med Sci 18(1):171\u2013182. https:\/\/doi.org\/10.5114\/aoms.2020.101072","journal-title":"Arch Med Sci"},{"issue":"2","key":"3861_CR66","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, Di Donato M, Pezone A et al (2020) ROS in cancer therapy: the bright side of the moon. Exp Mol Med 52(2):192\u2013203. https:\/\/doi.org\/10.1038\/s12276-020-0384-2","journal-title":"Exp Mol Med"},{"issue":"7","key":"3861_CR67","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s12032-023-02048-z","volume":"40","author":"L Periyasamy","year":"2023","unstructured":"Periyasamy L, Murugantham B, Muthusami S (2023) Plumbagin binds to epidermal growth factor receptor and mitigate the effects of epidermal growth factor micro-environment in PANC-1 cells. Med Oncol 40(7):184. https:\/\/doi.org\/10.1007\/s12032-023-02048-z","journal-title":"Med Oncol"},{"issue":"6","key":"3861_CR68","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/life13061303","volume":"13","author":"G Petrocelli","year":"2023","unstructured":"Petrocelli G, Marrazzo P, Bonsi L, Facchin F, Alviano F, Canaider S (2023) Plumbagin, a natural compound with several biological effects and anti-inflammatory properties. Life 13(6):1303. https:\/\/doi.org\/10.3390\/life13061303","journal-title":"Life"},{"key":"3861_CR69","doi-asserted-by":"publisher","first-page":"1248458","DOI":"10.3389\/fchem.2023.1248458","volume":"11","author":"A Rahaman","year":"2023","unstructured":"Rahaman A, Anjum F, Kumari A et al (2023) Deciphering the binding mechanism of an anticancer phytochemical plumbagin with calf thymus DNA using biophysical and in silico techniques. Front Chem 11:1248458. https:\/\/doi.org\/10.3389\/fchem.2023.1248458","journal-title":"Front Chem"},{"issue":"sup1","key":"3861_CR70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/21691401.2017.1417865","volume":"46","author":"S Rajalakshmi","year":"2018","unstructured":"Rajalakshmi S, Vyawahare N, Pawar A, Mahaparale P, Chellampillai B (2018) Current development in novel drug delivery systems of bioactive molecule plumbagin. Artif Cells Nanomed Biotechnol 46(sup1):209\u2013218. https:\/\/doi.org\/10.1080\/21691401.2017.1417865","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"3861_CR71","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1038\/s41598-017-06128-9","volume":"7","author":"G Rao","year":"2017","unstructured":"Rao G, Pierobon M, Kim IK et al (2017) Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations. Sci Rep 7(1):7066. https:\/\/doi.org\/10.1038\/s41598-017-06128-9","journal-title":"Sci Rep"},{"issue":"1","key":"3861_CR72","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1038\/s41598-018-20451-9","volume":"8","author":"G Rondeau","year":"2018","unstructured":"Rondeau G, Abedinpour P, Chrastina A, Pelayo J, Borgstrom P, Welsh J (2018) Differential gene expression induced by anticancer agent plumbagin is mediated by androgen receptor in prostate cancer cells. Sci Rep 8(1):2694. https:\/\/doi.org\/10.1038\/s41598-018-20451-9","journal-title":"Sci Rep"},{"issue":"6","key":"3861_CR73","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2174\/1389557520666201116144421","volume":"21","author":"A Roy","year":"2021","unstructured":"Roy A (2021) Plumbagin: a potential anticancer compound. Mini Rev Med Chem 21(6):731\u2013737. https:\/\/doi.org\/10.2174\/1389557520666201116144421","journal-title":"Mini Rev Med Chem"},{"key":"3861_CR74","first-page":"4293","volume":"28","author":"S Saha","year":"2023","unstructured":"Saha S, Saso L, Armagan G (2023) Cancer prevention and therapy by targeting oxidative stress pathways. MDPI 28:4293","journal-title":"MDPI"},{"issue":"2","key":"3861_CR75","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jin2.56","volume":"4","author":"I Sakpakdeejaroen","year":"2019","unstructured":"Sakpakdeejaroen I, Somani S, Laskar P, Mullin M, Dufes C (2019) Transferrin-bearing liposomes entrapping plumbagin for targeted cancer therapy. Interdiscip Nanomed 4(2):54\u201371. https:\/\/doi.org\/10.1002\/jin2.56","journal-title":"Interdiscip Nanomed"},{"key":"3861_CR76","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S293480","author":"I Sakpakdeejaroen","year":"2021","unstructured":"Sakpakdeejaroen I, Somani S, Laskar P, Mullin M, Duf\u00e8s C (2021) Regression of melanoma following intravenous injection of plumbagin entrapped in transferrin-conjugated, lipid\u2013polymer hybrid nano-particles. Int J Nanomed. https:\/\/doi.org\/10.2147\/IJN.S293480","journal-title":"Int J Nanomed"},{"key":"3861_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104517","author":"N Sakunrangsit","year":"2019","unstructured":"Sakunrangsit N, Ketchart W (2019) Plumbagin inhibits cancer stem-like cells, angiogenesis and suppresses cell proliferation and invasion by targeting Wnt\/\u03b2-catenin pathway in endocrine-resistant breast cancer. Pharmacol Res. https:\/\/doi.org\/10.1016\/j.phrs.2019.104517","journal-title":"Pharmacol Res"},{"issue":"6","key":"3861_CR78","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/nano9060821","volume":"9","author":"E S\u00e1nchez-L\u00f3pez","year":"2019","unstructured":"S\u00e1nchez-L\u00f3pez E, Guerra M, Dias-Ferreira J et al (2019) Current applications of nano-emulsions in cancer therapeutics. Nanomaterials 9(6):821. https:\/\/doi.org\/10.3390\/nano9060821","journal-title":"Nanomaterials"},{"key":"3861_CR79","doi-asserted-by":"crossref","unstructured":"Shah MA, Rogoff HA Implications of reactive oxygen species on cancer formation and its treatment. In: Seminars in Oncology, 2021. vol 48. Elsevier, p 238\u2013245","DOI":"10.1053\/j.seminoncol.2021.05.002"},{"key":"3861_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.628157","author":"HJ Shields","year":"2021","unstructured":"Shields HJ, Traa A, Van Raamsdonk JM (2021) Beneficial and detrimental effects of reactive oxygen species on lifespan: a comprehensive review of comparative and experimental studies. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.628157","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"3861_CR81","doi-asserted-by":"publisher","first-page":"13632","DOI":"10.1080\/21655979.2022.2081756","volume":"13","author":"C Shu","year":"2022","unstructured":"Shu C, Chen J, Lv M, Xi Y, Zheng J, Xu X (2022) Plumbagin relieves rheumatoid arthritis through nuclear factor-kappa-B (NF-kappaB) pathway. Bioengineered 13(5):13632\u201313642. https:\/\/doi.org\/10.1080\/21655979.2022.2081756","journal-title":"Bioengineered"},{"issue":"5","key":"3861_CR82","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/cbdd.14305","volume":"102","author":"J Shu","year":"2023","unstructured":"Shu J, Wang K, Zhao D, Zhou Y (2023) Plumbagin induces apoptosis, cell cycle arrest, and inhibits protein synthesis in LoVo colon cancer cells: a proteomic analysis. Chem Biol Drug Des 102(5):1075\u20131084. https:\/\/doi.org\/10.1111\/cbdd.14305","journal-title":"Chem Biol Drug Des"},{"key":"3861_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.02.005","author":"A Siddiqui","year":"2020","unstructured":"Siddiqui A, Ceppi P (2020) A non-proliferative role of pyrimidine metabolism in cancer. Mol Metab. https:\/\/doi.org\/10.1016\/j.molmet.2020.02.005","journal-title":"Mol Metab"},{"key":"3861_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2022.105512","author":"H Sidhu","year":"2023","unstructured":"Sidhu H, Capalash N (2023) Plumbagin downregulates UHRF1, p-Akt, MMP-2 and suppresses survival, growth and migration of cervical cancer CaSki cells. Toxicol in Vitro. https:\/\/doi.org\/10.1016\/j.tiv.2022.105512","journal-title":"Toxicol in Vitro"},{"key":"3861_CR85","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3390\/biomedicines11092340","volume":"11","author":"L Silva","year":"2023","unstructured":"Silva L, Fran\u00e7a W, Santos V et al (2023) Plumbagin: a promising in vivo antiparasitic candidate against schistosoma mansoni and in silico pharmacokinetic properties (ADMET. Biomedicines 11:2340","journal-title":"Biomedicines"},{"key":"3861_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.714370","author":"SA Sinenko","year":"2021","unstructured":"Sinenko SA, Starkova TY, Kuzmin AA, Tomilin AN (2021) Physiological signaling functions of reactive oxygen species in stem cells: from flies to man. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.714370","journal-title":"Front Cell Dev Biol"},{"key":"3861_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104501","author":"R Solanki","year":"2023","unstructured":"Solanki R, Saini M, Mochi J, Pappachan A, Patel S (2023) Synthesis, characterization, and anticancer studies of Plumbagin encapsulated albumin nano-particles for breast cancer treatment. J Drug Deliv Sci Tec. https:\/\/doi.org\/10.1016\/j.jddst.2023.104501","journal-title":"J Drug Deliv Sci Tec"},{"key":"3861_CR88","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1837278","author":"Y Su","year":"2022","unstructured":"Su Y, Li M, Wang Q et al (2022) Inhibition of the TLR\/NF-\u03baB signaling pathway and improvement of autophagy mediates neuroprotective effects of plumbagin in Parkinson\u2019s disease. Oxidat Med Cell Long. https:\/\/doi.org\/10.1155\/2022\/1837278","journal-title":"Oxidat Med Cell Long"},{"issue":"5","key":"3861_CR89","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.3390\/ijms22052779","volume":"22","author":"S Sultanli","year":"2021","unstructured":"Sultanli S, Ghumnani S, Ashma R, Kubatzky KF (2021) Plumbagin, a biomolecule with (anti)osteoclastic properties. Int J Mol Sci 22(5):2779. https:\/\/doi.org\/10.3390\/ijms22052779","journal-title":"Int J Mol Sci"},{"key":"3861_CR90","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301415R","author":"S Sultanli","year":"2023","unstructured":"Sultanli S, Schneider J, Burkart SS, Binder M, Kubatzky KF (2023) Cellular ROS tolerance determines the effect of plumbagin on osteoclast differentiation. FASEB J. https:\/\/doi.org\/10.1096\/fj.202301415R","journal-title":"FASEB J"},{"key":"3861_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112546","author":"S Sun","year":"2022","unstructured":"Sun S, Zhang Y, Xu W et al (2022) Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2021.112546","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"3861_CR92","doi-asserted-by":"publisher","first-page":"15996","DOI":"10.18632\/oncotarget.13723","volume":"8","author":"A Sznarkowska","year":"2017","unstructured":"Sznarkowska A, Kostecka A, Meller K, Bielawski KP (2017) Inhibition of cancer antioxidant defense by natural compounds. Oncotarget 8(9):15996\u201316016. https:\/\/doi.org\/10.18632\/oncotarget.13723","journal-title":"Oncotarget"},{"key":"3861_CR93","doi-asserted-by":"crossref","unstructured":"Tambe V, Ditani A, Rajpoot K, Tekade RK (2021) Pharmacokinetics aspects of structural modifications in drug design and therapy Biopharmaceutics and Pharmacokinetics Considerations. Elsevier, p 83\u2013108","DOI":"10.1016\/B978-0-12-814425-1.00014-0"},{"issue":"1","key":"3861_CR94","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/osi2.1107","volume":"19","author":"N Taneja","year":"2022","unstructured":"Taneja N, Alam A, Patnaik RS, Taneja T (2022) Unmasking the potential role of plant-based medicine \u201cPlumbagin\u201d in oral cancer\u2014A Novel Paradigm. Oral Sci Int 19(1):3\u201318. https:\/\/doi.org\/10.1002\/osi2.1107","journal-title":"Oral Sci Int"},{"key":"3861_CR95","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fphys.2021.627837","volume":"12","author":"H Tirichen","year":"2021","unstructured":"Tirichen H, Yaigoub H, Xu WW, Wu CX, Li RS, Li YF (2021) Mitochondrial reactive oxygen species and their contribution in chronic kidney disease progression through oxidative stress. Front Physiol 12:398","journal-title":"Front Physiol"},{"key":"3861_CR96","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.fct.2019.01.018","volume":"125","author":"SK Tripathi","year":"2019","unstructured":"Tripathi SK, Panda M, Biswal BKJF, Toxicology C (2019) Emerging role of plumbagin: cytotoxic potential and pharmaceutical relevance toward cancer therapy. Food Chem Toxicol 125:566\u2013582. https:\/\/doi.org\/10.1016\/j.fct.2019.01.018","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"3861_CR97","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s12272-020-01221-6","volume":"43","author":"SK Tripathi","year":"2020","unstructured":"Tripathi SK, Rengasamy KRR, Biswal BK (2020) Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction. Arch Pharm Res 43(2):242\u2013256. https:\/\/doi.org\/10.1007\/s12272-020-01221-6","journal-title":"Arch Pharm Res"},{"key":"3861_CR98","doi-asserted-by":"publisher","DOI":"10.1530\/REM-22-0023","author":"GE Valenti","year":"2023","unstructured":"Valenti GE, Tasso B, Traverso N, Domenicotti C, Marengo B (2023) Glutathione in cancer progression and chemoresistance: an update. Redox Exp Med. https:\/\/doi.org\/10.1530\/REM-22-0023","journal-title":"Redox Exp Med"},{"issue":"3","key":"3861_CR99","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/molecules25030596","volume":"25","author":"MdC Villegas-Aguilar","year":"2020","unstructured":"Villegas-Aguilar MdC, Fern\u00e1ndez-Ochoa \u00c1, MdlL C-G et al (2020) Pleiotropic biological effects of dietary phenolic compounds and their metabolites on energy metabolism, inflammation and aging. Molecules 25(3):596. https:\/\/doi.org\/10.3390\/molecules25030596","journal-title":"Molecules"},{"issue":"25","key":"3861_CR100","doi-asserted-by":"publisher","first-page":"16046","DOI":"10.1039\/d2ra03127b","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y, Sun X, Wang Y (2022) Synthesis of pH-responsive covalent organic frameworks nanocarrier for plumbagin delivery. RSC Adv 12(25):16046\u201316050. https:\/\/doi.org\/10.1039\/d2ra03127b","journal-title":"RSC Adv"},{"issue":"6","key":"3861_CR101","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","volume":"97","author":"B Wang","year":"2023","unstructured":"Wang B, Wang Y, Zhang J et al (2023a) ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol 97(6):1439\u20131451. https:\/\/doi.org\/10.1007\/s00204-023-03476-6","journal-title":"Arch Toxicol"},{"issue":"2","key":"3861_CR102","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/biom13020353","volume":"13","author":"R Wang","year":"2023","unstructured":"Wang R, Liang L, Matsumoto M, Iwata K, Umemura A, He F (2023b) Reactive oxygen species and NRF2 signaling, friends or foes in cancer? Biomolecules 13(2):353. https:\/\/doi.org\/10.3390\/biom13020353","journal-title":"Biomolecules"},{"key":"3861_CR103","first-page":"7","volume":"10","author":"B Wang","year":"2024","unstructured":"Wang B, Kong W, Lv L, Wang Z (2024) Plumbagin induces ferroptosis in colon cancer cells by regulating p53-related SLC7A11 expression. Heliyon 10:7","journal-title":"Heliyon"},{"key":"3861_CR104","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.2147\/DDDT.S204787","volume":"13","author":"Y Wei","year":"2019","unstructured":"Wei Y, Lv B, Xie J et al (2019) Plumbagin promotes human hepatoma SMMC-7721 cell apoptosis via caspase-3\/vimentin signal-mediated EMT. Drug Des Devel Ther 13:2343\u20132355. https:\/\/doi.org\/10.2147\/DDDT.S204787","journal-title":"Drug Des Devel Ther"},{"key":"3861_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.594833","author":"Y Wei","year":"2021","unstructured":"Wei Y, Lin Y, Chen W, Liu S, Jin L, Huang D (2021) Computational and in vitro analysis of plumbagin\u2019s molecular mechanism for the treatment of hepatocellular carcinoma. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.594833","journal-title":"Front Pharmacol"},{"key":"3861_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02502-9","author":"FR Weth","year":"2023","unstructured":"Weth FR, Hoggarth GB, Weth AF et al (2023) Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy. Br J Cancer. https:\/\/doi.org\/10.1038\/s41416-023-02502-9","journal-title":"Br J Cancer"},{"key":"3861_CR107","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3389\/fonc.2020.01479","volume":"10","author":"Y Xin","year":"2020","unstructured":"Xin Y, Li S, Jiang Q, Hu F, He Y, Zhang J (2020) Establishment of a jaw fibrosarcoma patient-derived xenograft and evaluation of the tumor suppression efficacy of plumbagin against jaw fibrosarcoma. Front Oncol 10:1479","journal-title":"Front Oncol"},{"issue":"21","key":"3861_CR108","doi-asserted-by":"publisher","first-page":"12225","DOI":"10.18632\/aging.205175","volume":"15","author":"Y Xin","year":"2023","unstructured":"Xin Y, Jiang Q, Liu C, Qiu J (2023) Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin. Aging (Albany NY) 15(21):12225","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"3861_CR109","doi-asserted-by":"publisher","first-page":"556","DOI":"10.21037\/tcr.2019.12.03","volume":"9","author":"C Yang","year":"2020","unstructured":"Yang C, Feng X, Li Z, He Q (2020a) Plumbagin inhibits tumor angiogenesis of gastric carcinoma in mice by modulating nuclear factor-kappa B pathway. Translat Cancer Res 9(2):556. https:\/\/doi.org\/10.21037\/tcr.2019.12.03","journal-title":"Translat Cancer Res"},{"issue":"2","key":"3861_CR110","doi-asserted-by":"publisher","first-page":"556","DOI":"10.21037\/tcr.2019.12.03","volume":"9","author":"C Yang","year":"2020","unstructured":"Yang C, Feng X, Li Z, He Q (2020b) Plumbagin inhibits tumor angiogenesis of gastric carcinoma in mice by modulating nuclear factor-kappa B pathway. Transl Cancer Res 9(2):556\u2013564. https:\/\/doi.org\/10.21037\/tcr.2019.12.03","journal-title":"Transl Cancer Res"},{"key":"3861_CR111","doi-asserted-by":"crossref","unstructured":"Yang Y, Cao Y The impact of VEGF on cancer metastasis and systemic disease. In: Seminars in Cancer Biology, 2022. vol 86. Elsevier, p 251\u2013261","DOI":"10.1016\/j.semcancer.2022.03.011"},{"key":"3861_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2023.03.263","volume":"203","author":"LY Yao","year":"2023","unstructured":"Yao LY, Yan D, Jiang BY et al (2023) Plumbagin is a novel GPX4 protein degrader that induces apoptosis in hepatocellular carcinoma cells. Free Radical Bio Med 203:1\u201310. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.03.263","journal-title":"Free Radical Bio Med"},{"key":"3861_CR113","doi-asserted-by":"publisher","first-page":"6940953","DOI":"10.1155\/2020\/6940953","volume":"2020","author":"Z Yin","year":"2020","unstructured":"Yin Z, Zhang J, Chen L et al (2020) Anticancer effects and mechanisms of action of plumbagin: review of research advances. Biomed Res Int 2020:6940953. https:\/\/doi.org\/10.1155\/2020\/6940953","journal-title":"Biomed Res Int"},{"issue":"2","key":"3861_CR114","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41416-022-01800-y","volume":"127","author":"S Zhan","year":"2022","unstructured":"Zhan S, Lu L, Pan S-s et al (2022) Targeting NQO1\/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth. Br J Cancer 127(2):364\u2013376. https:\/\/doi.org\/10.1038\/s41416-022-01800-y","journal-title":"Br J Cancer"},{"key":"3861_CR115","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.abb.2017.02.007","volume":"619","author":"J Zhang","year":"2017","unstructured":"Zhang J, Peng S, Li X, Liu R, Han X, Fang J (2017) Targeting thioredoxin reductase by plumbagin contributes to inducing apoptosis of HL-60 cells. Arch Biochem Biophys 619:16\u201326","journal-title":"Arch Biochem Biophys"},{"key":"3861_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-020-01607-y","volume":"20","author":"R Zhang","year":"2020","unstructured":"Zhang R, Wang Z, You W et al (2020a) Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K\/AKT\/mTOR signaling pathways and EMT. Cancer Cell Int 20:1\u201317. https:\/\/doi.org\/10.1186\/s12935-020-01607-y","journal-title":"Cancer Cell Int"},{"issue":"1","key":"3861_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-020-01607-y","volume":"20","author":"R Zhang","year":"2020","unstructured":"Zhang R, Wang Z, You W et al (2020b) Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K\/AKT\/mTOR signaling pathways and EMT. Cancer Cell Int 20(1):1\u201317. https:\/\/doi.org\/10.1186\/s12935-020-01607-y","journal-title":"Cancer Cell Int"},{"issue":"5","key":"3861_CR118","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/pharmaceutics13050706","volume":"13","author":"H Zhang","year":"2021","unstructured":"Zhang H, Zhang A, Gupte AA, Hamilton DJ (2021a) Plumbagin elicits cell-specific cytotoxic effects and metabolic responses in melanoma cells. Pharmaceutics 13(5):706. https:\/\/doi.org\/10.3390\/pharmaceutics13050706","journal-title":"Pharmaceutics"},{"key":"3861_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111957","author":"X Zhang","year":"2021","unstructured":"Zhang X, Kan H, Liu Y, Ding W (2021b) Plumbagin induces Ishikawa cell cycle arrest, autophagy, and apoptosis via the PI3K\/Akt signaling pathway in endometrial cancer. Food Chem Toxicol. https:\/\/doi.org\/10.1016\/j.fct.2020.111957","journal-title":"Food Chem Toxicol"},{"key":"3861_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2023.112432","author":"H-Q Zhang","year":"2024","unstructured":"Zhang H-Q, Lu X, Wu J-L et al (2024) Discovery of mitochondrion-targeting copper (II)-plumbagin and-bipyridine complexes as chemodynamic therapy agents with enhanced anti-tumor activity. Dalton Trans. https:\/\/doi.org\/10.1016\/j.jinorgbio.2023.112432","journal-title":"Dalton Trans"},{"key":"3861_CR121","doi-asserted-by":"publisher","first-page":"6110","DOI":"10.12659\/MSM.915782","volume":"25","author":"J Zhong","year":"2019","unstructured":"Zhong J, Li J, Wei J et al (2019) Plumbagin restrains hepatocellular carcinoma angiogenesis by stromal cell-derived factor (SDF-1)\/CXCR4-CXCR7 axis. Med Sci Mon Int Med J Exp Clin Res 25:6110. https:\/\/doi.org\/10.12659\/MSM.915782","journal-title":"Med Sci Mon Int Med J Exp Clin Res"},{"issue":"1","key":"3861_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-021-00250-z","volume":"9","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Tao L, Zhou X et al (2021) DHODH and cancer: promising prospects to be explored. Cancer Metab 9(1):1\u201325","journal-title":"Cancer Metab"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03861-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-024-03861-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03861-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T10:08:10Z","timestamp":1729246090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-024-03861-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":122,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["3861"],"URL":"https:\/\/doi.org\/10.1007\/s00204-024-03861-9","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}